Expression of CD44 splice variants in human skin and epidermal tumours

Virchows Archiv

Volumn 428, Issue 3, 1996, Pages 141-149

  Seiter, Simone ^a   Tilgen, Wolfgang ^a   Herrmann, Karin ^b   Schadendorf, Dirk ^c   Patzelt, Erik ^d   Möller, Peter ^a   Zöller, Margot ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Bender Gmbh   (Austria)

Author keywords

Basal cell carcinoma; CD44 variant isoforms; Skin; Spindle cell carcinoma

Indexed keywords

HERMES ANTIGEN; MONOCLONAL ANTIBODY;

ACINAR CELL; ANTIGEN EXPRESSION; APOCRINE GLAND; ARTICLE; BASAL CELL CARCINOMA; CARCINOMA CELL; CLINICAL ARTICLE; CONTROLLED STUDY; EPIDERMIS CELL; EXON; HAIR ROOT; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; PRIORITY JOURNAL; SEBACEOUS GLAND; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; STRATUM CORNEUM; SWEAT GLAND; TUMOR GROWTH;

EID: 0029967271     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00200656     Document Type: Article

References (60)

1. Arch R, Wirth K, Hofmann M, Ponta H, Matzku S, Herrlich P, Zöller M (1992) Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science 257: 682-685
2. Birch M, Mitchell S, Hart IR (1991) Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Res 51:6660-6667
3. Bosworth BT, St John T, Gallatin WM, Harp JA (1991) Sequence of the bovine CD44 cDNA: comparison with human and mouse sequences. Mol Immunol 28:1131-1135
4. Brown TA, Bouchard T, St John T, Wayner E, Carter WG (1991) Human keratinocytes express a new CD44 core protein (CD44E) as a heparan-sulfate intrinsic membrane proteoglycan with additional exons. J Cell Biol 113:207-221
5. Camp RL, Kraus TA, Pure E (1991) Variations in the cytoskeletal interaction and postranslational modification of the CD44 homing receptor in macrophages. J Cell Biol 115:1283-1292
6. Carter WG, Wayner EA (1988) Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J Biol Chem 263: 4193-4201
7. Cattoretti G, Berti E, Schiró R, D'Amato L, Valeggio C, Rilke F (1988) Improved avidin-biotin-peroxidase complex (ABC) staining. Histochem J 20:75-80
8. Cooper DL, Dougherty G, Harn HJ, Jackson S, Baptist EW, Byers J, Datta A, Phillips G, Isola NR (1992) The complex CD44 transcriptional unit: alternative splicing of three internal exons generates the epithelial form of CD44. Biochem Biophys Res Commun 182:569-578
9. Dougherty GJ, Lansdorp PM, Cooper DL, Humphries RK (1991) Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells. J Exp Med 174:1-5
10. East JA, Hart IR (1993) CD44 and its role in tumour progression and metastasis. Eur J Cancer 42:1921-1922
11. Faasen AE, Schrager JA, Klein DJ, Oegema TR, Couchman JR, McCarthy J (1992) A cell surface chondroilin sulfate proteoglycan, immunological related to CD44, is involved in type I collagen-mediated melanoma cell motility and invasion. J Cell Biol 116:521-531
12. Fox SB, Gatter KC, Jackson DG, Screaton GR, Bell MV, Bell JI, Harris AL, Simmons D, Fawcett J (1993) CD44 and cancer screening. Lancet 342:548-549
13. Fox SB, Fawcett J, Jackson DG, Collins I, Gatter KC, Harris AL, Gearing A, Simmons DL (1994) Normal human tissues, in addition to tumours, express multiple different CD44 isoforms. Cancer Res 54:4539-4546
14. Gjerset RA, Arya J, Volkman S, Haas M (1992) Association of induction of a fully tumorigenic phenotype in murine radiation-induced T-lymphoma cells with loss of differentiation antigens, gain of CD44, and alterations in p53 protein levels. Mol Carcinog 5:190-198
15. Günthert U (1993) CD44: a multitude of isoforms with diverse functions. Curr Top Microbiol Immunol 184:47-63
16. Günthert U, Hofmann M, Rudy W, Reber S, Zöller M, Haussmann I, Matzku S, Wenzel A, Ponta H, Herrlich P (1991) A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 65:13-24
17. Günthert U, Stauder R, Mayer B, Terpe HJ, Finke L, Friedrichs K (1995) Are CD44 variant isoforms involved in human tumour progression. Cancer Surv 24:19-42
18. Guo Y, Ma J, Wang J, Che X, Narula J, Bigby M, Wu M, Sy M-S (1994) Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody. Cancer Res 54:1561-1565
19. Guttinger M, Sutti F, Barnier C, McKay C, Berti E (1995) Expression of CD44 standard and variant forms in skin tumors. Loss of CD44 correlates with aggressive potential. Eur J Dermatol 5:398-406
20. Haggerty JG, Bretton RH, Milstone LM (1992) Identification and characterization of a cell surface proteoglycan on keratinocytes. J Invest Dermatol 99:374-380
21. Hardingham TE, Fosang AJ (1992) Proteoglycans: many forms and many functions. FASEB J 6:861-870
22. Haynes BF, Liao HX, Patton KL (1991) The transmembrane hyaluronate receptor (CD44): multiple functions, multiple forms. Cancer Cells 3:347-350
23. Herold-Mende C, Seiter S, Jourdan U, Herrmann K, Born AI, Patzelt E, Zöller J, Bosch FX, Zöller M (1996) Expression of splice variants of CD44 on squamous epithelia and squamous cell carcinoma of head and neck. J Pathol (in press)
24. Herrlich P, Pals S, Zöller M, Ponta H (1993) Metastasis meet lymphocytes. Immunol Today 14:395-399
25. Hofmann M, Rudy W, Zöller M, Tölg C, Ponta H, Herrlich P, Günthert U (1991) CD44 splice variants confer metastatic behaviour in rats: homologous sequences are expressed in human tumour cell lines. Cancer Res 51:5292-5297
26. Hughes EN, Colombatti A, August JT (1981) Murine cell surface glycoproteins. J Biol Chem 256:1014-1021
27. Idzerda RL, Carter WG, Nottenburg C, Wayner EA, Gallatin WM, St John T (1989) Isolation and DNA sequence of a cDNA clone encoding a lymphocyte adhesion receptor for high endothelium. Proc Natl Acad Sci USA 86:4659-4663
28. Jackson DG, Buckley J, Bell JI (1992) Multiple variants of the human lymphocyte homing receptor CD44 generated by insertions at a single site in the extracellular domain. J Biol Chem 267:4732-4739
29. Jalkanen S, Bargatze RF, Toyos J de los, Butcher EC (1986) A lymphoid cell surface protein involved in endothelial cell recognition and lymphocyte homing in man. Eur J Immunol 16: 1195-1202
30. Jalkanen S, Jalkanen M, Bargatze R, Tammi M, Butcher EC (1988) Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. J Immunol 141:1615-1623
31. Kaufmann M, Heider KH, Sinn HP, Minckwitz, G von, Ponta H, Herrlich P (1995) Surface expression of distinct CD44 variant exon epitopes on primary breast cancer strongly correlates with poor survival. Lancet 345:615-619
32. Kee BL, Dadi HK, Tran-Paterson R, Quackenbush EJ, Andrulis IL, Letarte M (1991) CD10 and CD44 genes of leukemic cells and malignant cell lines show no evidence of transformation-related alterations. J Cell Physiol 148:414-420
33. Koopmn G, Heider KH, Horts E, Adolf GR, Berg F van den, Ponta H, Herrlich P, Pals ST (1993) Activated human lymphocytes and aggressive non-Hodgkin's lymphoma express a homologue of the rat metastasis-associated variant of CD44. J Exp Med 117:897-904
34. Kugelman LC, Ganguly S, Haggerty JG, Weissman SM, Milstone LM (1992) The core protein of epican, a heparan sulfate proteoglycan on keratinocytes, is an anternative form of CD44. J Invest Dermatol 99:381-385
35. Lokeshwar VB, Bourguignon LYW (1991) Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis. J Biol Chem 266: 17983-17989
36. Mackay CR, Terpe HJ, Stauder R, Marston WL, Stark H, Günthert U (1994) Expression and modulation of CD44 variant isoforms in humans. J Cell Biol 124:71-82
37. Matsumura Y, Tarin D (1993) Significance of CD44 gene products for cancer diagnosis and disease evaluation. Lancet 340:1053-1058
38. Moll J, Schmidt A, Arch R, Putten H van der, Plug R, Ponta H, Herrlich P, Zöller M (1996) Accelerated T cell responsiveness in variant CD44 expression transgenic mice. J Immunol 156:2085-2094
39. Omary MB, Trowbridge IS, Letarte M, Kagnoff MF, Isacke CM (1988) Structural heterogeneity of human Pgp-1 and its relationship with p85. Immunogenetics 27:460-464
40. Penneys NS, Kaiser M (1993) Cylindroma expresses immunohistochemical markers linking it to eccrine coil. J Cutan Pathol 20:40-43
41. Picker LJ, Nakache M, Butcher EC (1989) Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types. J Cell Biol 109:927-937
42. Rudy W, Hofmann M, Schwartz-Albiez R, Zöller M, Heider K-H, Ponta H, Herrlich P (1993) The two major CD44 proteins expressed on a metastatic rat tumour cell line are derived from different splice variants: each one individually suffices to confer metastatic behaviour. Cancer Res 53:1262-1268
43. Salmi M, Gron-Virta K, Sointu P, Grenman R, Kalimo H, Jalkanen S (1993) Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin. J Cell Biol 122:431-442
44. Sawaya ME, Bakshandeh H, Hordinsky MK, Penneys NS (1994) CD44 expression in alopecia areata and androgenetic alopecia. J Cutan Pathol 21:229-232
45. Screaton GR, Bell MV, Jackson DG, Cornelis FB, Gerth U, Bell JI (1992) Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA 89:12160-12164
46. Screaton GR, Bell MV, Bell JI, Jackson DG (1993) The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat. J Biol Chem 268:12235-12238
47. Seiter S, Schadendorf D, Herrmann K, Schneider M, Rösel M, Arch R, Tilgen W, Zöller M (1996) Expression of splice variants of CD44 during melanoma progression. Clin Cancer Res 2:447-456
48. Shtivelman E, Bishop JM (1991) Expression of CD44 is repressed in neuroblastoma cells. Mol Cell Biol 11:5446-5453
49. Stamenkovic L, Aruffo A, Amiot M, Seed B (1991) The hematopoietic and epithelial forms of CD44 are distinct polypeptides with different adhesion potentials for hyaluronate-bearing cells. EMBO J 10:343-348
50. Tanabe KK, Saya H (1994) The CD44 adhesion molecule and metastasis. Crit Rev Oncogenesis 5:2-3
51. Terpe HJ, Stark H, Prehm P, Günthert U (1994) CD44 variant isoforms are expressed preferentially in basal epithelia of non-malignant human fetal and adult tissues. Histochemistry 101: 79-89
52. Tölg C, Hofmann M, Herrlich P, Ponta H (1993) Splicing choice from ten variant exons establishes CD44 variability. Nucleic Acids Res 21:1225-1229
53. Wang C, Tammi M, Tammi R (1992) Distribution of hyaluronan and its CD44 receptor in the epithelia of human skin appendages. Histochemistry 98:105-112
54. Weering DH van, Baas PD, Bos JL (1993) A PCR-based method for the analysis of human CD44 splice products. PCR Methods Appl 3:100-106
55. Wielenga VJM, Heider KH, Offerhaus JA, Adolf GR, Berg FM van den, Ponta H, Herrlich P, Pals ST (1993) Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Res 53:4754-4756
56. Wirth K, Arch R, Somasundaram C, Hofmann M, Weber B, Herrlich P, Matzku S, Zöller M (1993) Expression of CD44 isoforms carrying metastasis-associated sequences in newborn and adult rats. Eur J Cancer 291:1172-1177
57. Yasaka N, Furue M, Tamaki K (1995) CD44 expression in normal human skin and skin tumors. J Dermatol 22:88-94
58. Zöller M (1995) Function of variant isoforms of CD44 in lymphocyte activation and lymphatic spread of tumor cells. In: Siess W, Lorenz R, Weber PC (eds) Adhesion molecules and cell signalling: biological and clinical applications, vol 1. Raven Press, New York, pp 201-218
59. Zöller M (1995) CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation. J Mol Med 73:425-438
60. Zöller M, Kaufmann M (1994) CD44 and metastasis. Onkologie 17:114-122